Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy

Abstract

NCT01042743 (http://www.clinicaltrials.gov).

The da Vinci Xi: a review of its capabilities, versatility, and potential role in robotic colorectal surgery

“…19 Of the 24 studies included in the meta-analysis by Zhang et al, 17 were retrospective, and only the two by Jiménez-Rodríguez et al and Park et al were randomized trials. [20][21][22] All seven articles in the 2014 publication by Xu et al were included in a 2015 publication by Chang et al, and some of these articles also contributed to half of the meta-analysis by Zarak et al 11,12,[22][23][24][25][26] Between 2014 and 2016, three different journals separately published meta-analyses on robotic versus laparoscopic rectal cancer surgery -all included the same eight studies and 1229 patients. [27][28][29] Two of these publications were authored by the same group.…”

Innovations and developments in surgical coloproctology

“…All these benefits must be offset against the significant costs for both the apparatus and its disposable instruments. 16 …”

Chirurgia robotowa: nowa jakość i przełom w leczeniu czy kosztowny gadżet?

“…Niezmiennie jednym z głównych argumentów przeciwko zastosowaniu robota w chirurgii onkologicznej pozostają wysokie koszty operacji robotowych. Pobyt w szpitalu pacjenta operowanego z zastosowaniem robota jest o 20-30% droższy niż pacjenta operowanego metodą laparoskopową [23][24][25]. Wynika to głównie z wysokiej ceny systemu da Vinci oraz kosztów jego eksploatacji.…”